Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 24:17:4335-4346.
doi: 10.2147/IJGM.S476736. eCollection 2024.

Importance of H-FABP in Early Diagnosis of Acute Myocardial Infarction

Andreea Licuta Pavel  1 , Nilima Rajpal Kundnani  1   2 , Stelian I Morariu  3 , Anca Tudor  4 , Dana Emilia Man  1   2 , Daniel Marius Duda-Seiman  1   2 , Dana Emilia Velimirovici  1   2 , Mihaela Daniela Valcovici  1   2 , Pop Calin  3   5 , Simona Ruxanda Dragan  1   2
Affiliations

Importance of H-FABP in Early Diagnosis of Acute Myocardial Infarction

Andreea Licuta Pavel et al. Int J Gen Med. .

Abstract

Background: Over the years, troponins have aced the para-clinical tests for confirming the diagnosis of acute myocardial infarction. However, the rise in their levels is entirely time-dependent, which can cause a delay in the initiation of treatment protocols. Heart fatty acid binding protein (H-FABP) can serve comparatively as a better biological marker for overcoming this flaw of troponins, as it is quickly released into the bloodstream once the myocardial injury occurs due to decreased blood supply. This study aimed to evaluate the usefulness of this marker as well as establish the specificity and sensitivity of testing the H-FABP, if it adds to early diagnosis and can be relied upon in the future.

Material and methods: We evaluated 83 patients and their H-FABP levels, along with the standard cardiac markers like hsTni and CK-MB, in patients presenting with symptoms indicating an ongoing coronary event, who had presented to our hospital between August 2020 and June 2021. The patients were divided into two groups: group 1 comprised patients who had first medical contact within 4 hours of the onset of chest pain, and group 2 patients who had first medical contact after 4 hours of the appearance of symptoms. Statistical analysis was performed using MedCalc v20.023, considering statistical significance values of p <0.05. Results for targeted variables are presented using descriptive statistics (mean, standard deviation, range, median, and associated interquartile range) for continuous data, and counts with associated percentages for categorical data.

Results: H-FABP was found to have better sensitivity and specificity of 89.67 and 95.65 in group 1 patients and 86.73 and 49.84, respectively, in group 2 patients. The other two cardiac biomarkers evaluated had lower values in response to H-FABP in the first 4 hours of presentation. Results for group 2 showed that specificitivity for hsTni is higher than that of H-FABP, that is, 69.98.

Conclusion: Heart fatty acid binding protein (H-FABP) should be included in the protocol for biochemical evaluation of all patients presenting to the emergency services with a suspicion of possible myocardial infarction. Early detection of this protein can help in effective and timely management of myocardial infarction, thus further decreasing mortality rates and the financial burden on healthcare systems worldwide.

Keywords: H-FABP; acute coronary syndrome; cardiac biomarker; heart fatty acid binding protein; myocardial infarction; troponin.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest.

Figures

Figure 1
Figure 1
Patient distribution according to the moment of first medical contact, type of myocardial infarction, and number of vessels involved.
Figure 2
Figure 2
Pairwise comparison of ROC curves for patients included in group 1.
Figure 3
Figure 3
Pairwise comparison of ROC curves for patients included in group 2.
See this image and copyright information in PMC

References

    1. Dauerman HL, Ibanez B. The Edge of Time in Acute Myocardial Infarction. J Am Coll Cardiol. 2021;77(15):1871–1874. doi:10.1016/j.jacc.2021.03.003 PubMed PMID: 33858623. - DOI - PubMed
    1. Aso S, Imamura H, Sekiguchi Y, et al. Incidence and mortality of acute myocardial infarction. A population-based study including patients with out-of-hospital cardiac arrest. Int Heart J. 2011;52(4):197–202. doi:10.1536/ihj.52.197 PubMed PMID: 21828943. - DOI - PubMed
    1. Stengaard C, Sørensen JT, Rasmussen MB, Bøtker MT, Pedersen CK, Terkelsen CJ. Prehospital diagnosis of patients with acute myocardial infarction. Diagnosis. 2016;3(4):155–166. doi:10.1515/dx-2016-0021 PubMed PMID: 29536903. - DOI - PubMed
    1. Lee YM, Kim RB, Lee HJ, et al. Relationships among medication adherence, lifestyle modification, and health-related quality of life in patients with acute myocardial infarction: a cross-sectional study. Health Qual Life Outcomes. 2018. 16(1):100. 10.1186/s12955-018-0921-z. Epub 20180522. PubMed PMID: 29788961; PubMed Central PMCID: PMC5964665. - DOI - PMC - PubMed
    1. Zeymer U. Diagnosis and initial management of acute myocardial infarction. MMW Fortschr Med. 2019;161(4):34–36. doi:10.1007/s15006-019-0223-3 PubMed PMID: 30830611. - DOI - PubMed